Annual report pursuant to Section 13 and 15(d)

12. Share-Based Compensation (Details Narrative)

v3.7.0.1
12. Share-Based Compensation (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Share based compensation $ 1,922,215 $ 2,201,452  
Stock granted for services, value 1,174,637    
Modification of Options [Member]      
Incremental compensation expense 24,000 $ 25,008  
Modification of Options [Member] | Modify Vesting and Exercise Price [Member]      
Incremental compensation expense $ 165,000    
FDS Pharma [Member]      
Stock granted for services, shares   3,244,784  
Stock granted for services, value   $ 812,000  
Employee Stock Options [Member]      
Options granted 603,622 493,945  
Weighted average grant date fair value $ 2.94 $ 9.35  
Options exercised 0 0  
Proceeds from exercise of stock options $ 0 $ 101,933  
Options vested 212,472 161,657  
Fair value of options vested $ 1,700,335 $ 1,391,450  
Unrecognized compensation expense $ 2,866,432    
Unrecognized compensation expense recognition period 2 years 4 months 24 days    
Employee Stock Options [Member] | Stock Plan [Member]      
Options granted 365,972    
Employee Stock Options [Member] | New Equity Plan [Member]      
Options granted 237,650    
Non Employee Stock Options [Member]      
Options granted   30,304  
Weighted average grant date fair value   $ 13.13  
Options exercised   0  
Options vested 17,857 17,857  
Fair value of options vested $ 196,306 $ 195,575  
Unrecognized compensation expense $ 90,268    
Unrecognized compensation expense recognition period 1 year 6 months    
Common Stock Awards [Member]      
Stock granted for services, shares 26,760 34,402  
Stock granted for services, value $ 180,971 $ 392,661  
Other than options outstanding 29,790 22,887 19,622
JSOP [Member]      
Other than options outstanding 323,885 323,885